Asia-Pacific Plasma Therapy Market to be Worth $214 Million by 2030 – Exclusive Report by Meticulous Research®

Redding, California, July 27, 2023 (GLOBE NEWSWIRE) — According to a new market research report, ‘Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), and End User (Hospitals & Clinics, Research Institutes) – Forecast to 2030,’ published by Meticulous Research^®, the Asia-Pacific plasma therapy market is expected to reach $214 million by 2030 at a CAGR of 13.4% from 2023 to 2030.

Plasma therapy is a part of regenerative medicine that uses injections of a concentration of patients’ platelets to speed up the healing process of injured joints, ligaments, tendons, and muscles. Alternatively, platelet-rich plasma (PRP) therapy uses an individual patient’s healing system to recover from musculoskeletal problems. PRP therapy is also used in cosmetics to treat hyperpigmentation, reduce acne scars, stimulate collagen production, improve hair health, and others.

Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5556

The growth of the Asia-Pacific plasma therapy market is attributed to the increasing awareness of platelet-rich plasma (PRP) therapy, rising healthcare expenditure in Asia-Pacific countries, and increasing cosmetic procedures. However, the stringent regulatory framework for PRP use is the major challenging factor observed in this market, and the availability of alternatives for PRP treatment and side effects associated with PRP may restrain the growth of the platelet-rich plasma (PRP) therapy market to some extent during the forecast period.

Increasing Applications of PRP Treatments is Providing Opportunities for Market Growth

With the rapid boom of cosmetic and aesthetic procedures, platelet-rich plasma has paved the way in therapeutic applications. Highly advanced orthopedic facilities and multispecialty hospitals have professionals considering platelet-rich plasma as an effective pain management strategy among people undergoing orthopedic surgeries or suffering from conditions such as arthritis, tennis knee, and tendonitis.

Furthermore, the treatment has applications in acute sports injuries, including thigh and knee sprains. The increasing prevalence of sports injuries in Asia-Pacific has provided market growth opportunities in recent years. For instance, according to the Australian Institute of Health and Welfare, 66,500 sport injury-related hospitalizations were recorded in 2020–2021. PRP therapy has been gaining traction in dermatological applications such as wound healing, scar revision, skin regeneration and rejuvenation, and alopecia.

PRP has also been researched for its beneficial effects in cancer treatment. According to a research article published in Helion in March 2020, PRP was a feasible therapeutic alternative to treat bladder cancer. The research stated that new aspects concerning nitric oxide’s ability to restrain platelet adhesion and aggregation for slowing metastasis in cancer offer an important advantage to cancer patients. The rising applications of platelet-rich plasma in medical therapies and procedures are expected to offer significant growth opportunities to the market players operating in the Asia-Pacific plasma therapy market.

Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5556

The report includes an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past years (2020–2023). The key players operating in the Asia-Pacific plasma therapy market are Arthrex, Inc. (U.S.) DePuy Synthesis, Inc. (Johnson & Johnson) (U.S.), Global Stem Cells Group, Inc.(U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.) Zimmer Biomet Holdings, Inc. (U.S.), Exactech Inc. (U.S.), Beijing Manson Technology Co., Ltd. (China), Alocuro (Australia), Takeda Pharmaceutical Company Limited (Japan), Grifols, S.A.(Spain), Octapharma AG (Switzerland), and CSL Limited (Australia).

The Asia-Pacific plasma therapy market is segmented by Type (Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin, and Leukocyte and Platelet-rich Fibrin), Application (Orthopedics & Traumatology, Rheumatology, Dermatology & Cosmetology, Ophthalmology, Stomatology & Odontology, and Other Applications), End User (Hospitals & Clinics & Research Institutes), and country. The study also evaluates industry competitors and analyzes their market share at the country level.

Among all types studied in this report, the leukocyte-rich PRP segment is expected to record the highest CAGR during the forecast period. The growth of the leukocyte-rich PRP segment is driven by the application of leukocyte-rich PRP to treat ankle sprains, muscle injuries, fractures, aesthetic plastic surgery, regenerative medicine, and skin and chronic wound healing. Additionally, leukocyte- and platelet-rich plasma (L-PRP) consists of high concentrations of platelets, leukocytes, and other bioactivities that play a prominent role in bone and soft tissue healing processes. Thus, the positive effects of L-PRP in certain medical applications for therapeutic purposes are expected to account for the segment’s growth over the forecast years.

Quick Buy – Asia-Pacific Plasma Therapy Market- Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/82357590

Among all applications studied in this report, in 2023, the orthopedics & traumatology segment is expected to account for the largest share of the market. The largest market share of the segment is attributed to the improved healing process, less recovery time, significant pain relief, and minimally invasive procedures.

Among all end users studied in this report, in 2023, the hospital & clinics segment is expected to account for the largest share of the market. The largest market share of the segment is attributed to the increasing number of arthritis patients receiving PRP therapy as a part of disease management is likely to increase patient footfall in hospitals & clinics. Additionally, due to fewer side effects and higher efficacy in hair restoration, doctors and physicians prescribing PRP treatment to patients for hair restoration contribute to the largest share of the segment.

Among all countries studied in this report, in 2023, Japan is expected to account for the largest share of the Asia-Pacific plasma therapy market. The large market share of the country is attributed to the growing number of accidents in the country, and growth in the geriatric population is increasing the demand for dermatological, orthopedic, ophthalmology, and other applications of PRP therapy. For instance, according to the data published by the World Bank Group, in 2021, 37.4 million were aged 65 years and above, an increase from 34.7 million in 2015.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/asia-pacific-plasma-therapy-market-5556

Scope of the Report:

Asia-Pacific Plasma Therapy Market Assessment – by Type

• Pure PRP
• Leukocyte-rich PRP
• Pure Platelet-rich Fibrin
• Leukocyte And Platelet-rich Fibrin (L-PRF)

Asia-Pacific Plasma Therapy Market Assessment – by Application

• Orthopedics & Traumatology
• Rheumatology
• Dermatology & Cosmetology
• Ophthalmology
• Stomatology & Odontology
• Other Applications

(Other Applications include Sexual Health, Infertility Support, Migraine, and Neurological Issues.)

Asia-Pacific Plasma Therapy Market Assessment – by End User

• Hospitals & Clinics
• Research Institutes

Asia-Pacific Plasma Therapy Market Assessment – by Country

• China
• Japan
• India
• South Korea
• Australia
• Singapore
• Rest of Asia Pacific

Request Free Report Sample Now: https://www.meticulousresearch.com/request-sample-report/cp_id=5556

Related Reports:

Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes) – Global Forecast to 2028

https://www.meticulousresearch.com/product/plasma-therapy-market-5218

Negative Pressure Wound Therapy (NPWT) Market By Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer [DFU], Venous Leg Ulcer, Surgical, Burn, Skin Grafts), End User (Hospital, Home Care) – Global Forecast to 2030

https://www.meticulousresearch.com/product/negative-pressure-wound-therapy-market-5535

CAR T-cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]), Target Antigen (CD, BCMA, HER2), Indication (Lymphoma, ALL, AML, Multiple Myeloma) – Global Forecast to 2030

https://www.meticulousresearch.com/product/car-t-cell-therapy-market-5508

Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) – Global Forecast to 2030

https://www.meticulousresearch.com/product/bone-growth-stimulator-market-3530

Recombinant Coagulation Factors Market by Type (Factor VIII, Factor IX), Source (CHO, HEK), Application (Hemophilia (Type A, Type B), Others), End User (Hospitals, Clinical Research Laboratories) – Global Forecast to 2030

https://www.meticulousresearch.com/product/recombinant-coagulation-factors-market-1254

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected] 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/786/asia-pacific-plasma-therapy-market-2030